Compile Data Set for Download or QSAR
Report error Found 1463 of affinity data for UniProtKB/TrEMBL: P21675
TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50572134(CHEMBL4868363)
Affinity DataKi:  0.200nMAssay Description:Inhibition of human partial length TAF1 bromodomain 2 (D1521 to D1656 residues) expressed in bacterial expression system by BROMOscan assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2022
Entry Details Article
PubMed
TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50572127(CHEMBL4850335)
Affinity DataKi:  0.398nMAssay Description:Inhibition of human partial length TAF1 bromodomain 2 (D1521 to D1656 residues) expressed in bacterial expression system by BROMOscan assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2022
Entry Details Article
PubMed
TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50572130(CHEMBL4864027)
Affinity DataKi:  0.794nMAssay Description:Inhibition of human partial length TAF1 bromodomain 2 (D1521 to D1656 residues) expressed in bacterial expression system by BROMOscan assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2022
Entry Details Article
PubMed
TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM346986(US10202379, Reference Example 730)
Affinity DataEC50:  0.799nMAssay Description:A test sample was diluted with a culture medium to an appropriate concentration in advance, and then 2 to 5-fold serial dilution on a 96 well plate (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50572131(CHEMBL4873236)
Affinity DataKi:  1nMAssay Description:Inhibition of human partial length TAF1 bromodomain 2 (D1521 to D1656 residues) expressed in bacterial expression system by BROMOscan assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2022
Entry Details Article
PubMed
TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM346956(US10202379, Reference Example 654)
Affinity DataEC50:  1nMAssay Description:A test sample was diluted with a culture medium to an appropriate concentration in advance, and then 2 to 5-fold serial dilution on a 96 well plate (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50572133(CHEMBL4854161)
Affinity DataKi:  1.30nMAssay Description:Inhibition of human partial length TAF1 bromodomain 2 (D1521 to D1656 residues) expressed in bacterial expression system by BROMOscan assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2022
Entry Details Article
PubMed
TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM346932(US10202379, Reference Example 621)
Affinity DataEC50:  2nMAssay Description:A test sample was diluted with a culture medium to an appropriate concentration in advance, and then 2 to 5-fold serial dilution on a 96 well plate (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM346987(US10202379, Reference Example 731)
Affinity DataEC50:  2.08nMAssay Description:A test sample was diluted with a culture medium to an appropriate concentration in advance, and then 2 to 5-fold serial dilution on a 96 well plate (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM346986(US10202379, Reference Example 730)
Affinity DataIC50: 2.52nMAssay Description:A test sample was diluted with a culture medium to an appropriate concentration in advance, and then 2 to 5-fold serial dilution on a 96 well plate (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM346979(US10202379, Reference Example 719)
Affinity DataIC50: 2.60nMAssay Description:A test sample was diluted with a culture medium to an appropriate concentration in advance, and then 2 to 5-fold serial dilution on a 96 well plate (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM346819(US10202379, Reference Example 444)
Affinity DataEC50:  3nMAssay Description:A test sample was diluted with a culture medium to an appropriate concentration in advance, and then 2 to 5-fold serial dilution on a 96 well plate (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM346806(US10202379, Reference Example 417)
Affinity DataEC50:  3nMAssay Description:A test sample was diluted with a culture medium to an appropriate concentration in advance, and then 2 to 5-fold serial dilution on a 96 well plate (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM346934(US10202379, Reference Example 623)
Affinity DataEC50:  3nMAssay Description:A test sample was diluted with a culture medium to an appropriate concentration in advance, and then 2 to 5-fold serial dilution on a 96 well plate (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM346840(US10202379, Reference Example 470)
Affinity DataEC50:  3nMAssay Description:A test sample was diluted with a culture medium to an appropriate concentration in advance, and then 2 to 5-fold serial dilution on a 96 well plate (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM346972(US10202379, Reference Example 707)
Affinity DataEC50:  3.05nMAssay Description:A test sample was diluted with a culture medium to an appropriate concentration in advance, and then 2 to 5-fold serial dilution on a 96 well plate (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM346990(US10202379, Reference Example 752)
Affinity DataEC50:  3.12nMAssay Description:A test sample was diluted with a culture medium to an appropriate concentration in advance, and then 2 to 5-fold serial dilution on a 96 well plate (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM346964(US10202379, Reference Example 666)
Affinity DataIC50: 3.36nMAssay Description:A test sample was diluted with a culture medium to an appropriate concentration in advance, and then 2 to 5-fold serial dilution on a 96 well plate (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM346970(US10202379, Reference Example 704)
Affinity DataEC50:  3.5nMAssay Description:A test sample was diluted with a culture medium to an appropriate concentration in advance, and then 2 to 5-fold serial dilution on a 96 well plate (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM346966(US10202379, Reference Example 682)
Affinity DataEC50:  3.5nMAssay Description:A test sample was diluted with a culture medium to an appropriate concentration in advance, and then 2 to 5-fold serial dilution on a 96 well plate (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM346988(US10202379, Reference Example 741)
Affinity DataEC50:  3.51nMAssay Description:A test sample was diluted with a culture medium to an appropriate concentration in advance, and then 2 to 5-fold serial dilution on a 96 well plate (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM346993(US10202379, Reference Example 768)
Affinity DataEC50:  3.64nMAssay Description:A test sample was diluted with a culture medium to an appropriate concentration in advance, and then 2 to 5-fold serial dilution on a 96 well plate (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM346968(US10202379, Reference Example 691)
Affinity DataIC50: 3.67nMAssay Description:A test sample was diluted with a culture medium to an appropriate concentration in advance, and then 2 to 5-fold serial dilution on a 96 well plate (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM346995(US10202379, Reference Example 772)
Affinity DataEC50:  3.68nMAssay Description:A test sample was diluted with a culture medium to an appropriate concentration in advance, and then 2 to 5-fold serial dilution on a 96 well plate (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM346984(US10202379, Reference Example 726)
Affinity DataIC50: 3.74nMAssay Description:A test sample was diluted with a culture medium to an appropriate concentration in advance, and then 2 to 5-fold serial dilution on a 96 well plate (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM346980(US10202379, Reference Example 721 | US10202379, Re...)
Affinity DataEC50:  3.78nMAssay Description:A test sample was diluted with a culture medium to an appropriate concentration in advance, and then 2 to 5-fold serial dilution on a 96 well plate (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM346965(US10202379, Reference Example 668)
Affinity DataEC50:  3.84nMAssay Description:A test sample was diluted with a culture medium to an appropriate concentration in advance, and then 2 to 5-fold serial dilution on a 96 well plate (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM346964(US10202379, Reference Example 666)
Affinity DataEC50:  3.91nMAssay Description:A test sample was diluted with a culture medium to an appropriate concentration in advance, and then 2 to 5-fold serial dilution on a 96 well plate (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM346984(US10202379, Reference Example 726)
Affinity DataEC50:  3.93nMAssay Description:A test sample was diluted with a culture medium to an appropriate concentration in advance, and then 2 to 5-fold serial dilution on a 96 well plate (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM346980(US10202379, Reference Example 721 | US10202379, Re...)
Affinity DataEC50:  3.95nMAssay Description:A test sample was diluted with a culture medium to an appropriate concentration in advance, and then 2 to 5-fold serial dilution on a 96 well plate (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM346923(US10202379, Reference Example 602)
Affinity DataEC50:  4nMAssay Description:A test sample was diluted with a culture medium to an appropriate concentration in advance, and then 2 to 5-fold serial dilution on a 96 well plate (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM346818(US10202379, Reference Example 443)
Affinity DataEC50:  4nMAssay Description:A test sample was diluted with a culture medium to an appropriate concentration in advance, and then 2 to 5-fold serial dilution on a 96 well plate (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM346917(US10202379, Reference Example 594)
Affinity DataEC50:  4nMAssay Description:A test sample was diluted with a culture medium to an appropriate concentration in advance, and then 2 to 5-fold serial dilution on a 96 well plate (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM346812(US10202379, Reference Example 429)
Affinity DataEC50:  4nMAssay Description:A test sample was diluted with a culture medium to an appropriate concentration in advance, and then 2 to 5-fold serial dilution on a 96 well plate (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM346820(US10202379, Reference Example 445)
Affinity DataEC50:  4nMAssay Description:A test sample was diluted with a culture medium to an appropriate concentration in advance, and then 2 to 5-fold serial dilution on a 96 well plate (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM346828(US10202379, Reference Example 454)
Affinity DataEC50:  4nMAssay Description:A test sample was diluted with a culture medium to an appropriate concentration in advance, and then 2 to 5-fold serial dilution on a 96 well plate (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM346839(US10202379, Reference Example 469)
Affinity DataEC50:  4nMAssay Description:A test sample was diluted with a culture medium to an appropriate concentration in advance, and then 2 to 5-fold serial dilution on a 96 well plate (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM346830(US10202379, Reference Example 456)
Affinity DataEC50:  4nMAssay Description:A test sample was diluted with a culture medium to an appropriate concentration in advance, and then 2 to 5-fold serial dilution on a 96 well plate (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50503407(CHEMBL4440829)
Affinity DataIC50: 4nMAssay Description:Inhibition of recombinant His-tagged TAF1 bromodomain 2 (unknown origin) after 10 mins by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM346994(US10202379, Reference Example 771)
Affinity DataEC50:  4.05nMAssay Description:A test sample was diluted with a culture medium to an appropriate concentration in advance, and then 2 to 5-fold serial dilution on a 96 well plate (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM346968(US10202379, Reference Example 691)
Affinity DataEC50:  4.05nMAssay Description:A test sample was diluted with a culture medium to an appropriate concentration in advance, and then 2 to 5-fold serial dilution on a 96 well plate (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM346976(US10202379, Reference Example 711)
Affinity DataEC50:  4.28nMAssay Description:A test sample was diluted with a culture medium to an appropriate concentration in advance, and then 2 to 5-fold serial dilution on a 96 well plate (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM346985(US10202379, Reference Example 728)
Affinity DataEC50:  4.32nMAssay Description:A test sample was diluted with a culture medium to an appropriate concentration in advance, and then 2 to 5-fold serial dilution on a 96 well plate (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM346723(US10202379, Reference Example 326)
Affinity DataEC50:  5nMAssay Description:A test sample was diluted with a culture medium to an appropriate concentration in advance, and then 2 to 5-fold serial dilution on a 96 well plate (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM346963(US10202379, Reference Example 665)
Affinity DataEC50:  5nMAssay Description:A test sample was diluted with a culture medium to an appropriate concentration in advance, and then 2 to 5-fold serial dilution on a 96 well plate (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM346802(US10202379, Reference Example 413)
Affinity DataEC50:  5nMAssay Description:A test sample was diluted with a culture medium to an appropriate concentration in advance, and then 2 to 5-fold serial dilution on a 96 well plate (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM346923(US10202379, Reference Example 602)
Affinity DataIC50: 5nMAssay Description:A test sample was diluted with a culture medium to an appropriate concentration in advance, and then 2 to 5-fold serial dilution on a 96 well plate (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM346931(US10202379, Reference Example 619)
Affinity DataIC50: 5nMAssay Description:A test sample was diluted with a culture medium to an appropriate concentration in advance, and then 2 to 5-fold serial dilution on a 96 well plate (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM346837(US10202379, Reference Example 463)
Affinity DataEC50:  5nMAssay Description:A test sample was diluted with a culture medium to an appropriate concentration in advance, and then 2 to 5-fold serial dilution on a 96 well plate (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTranscription initiation factor TFIID subunit 1(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM346919(US10202379, Reference Example 598)
Affinity DataEC50:  5nMAssay Description:A test sample was diluted with a culture medium to an appropriate concentration in advance, and then 2 to 5-fold serial dilution on a 96 well plate (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

Displayed 1 to 50 (of 1463 total ) | Next | Last >>
Jump to: